Results 111 to 120 of about 377 (154)

Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations. [PDF]

J Am Heart Assoc
Kwon Y, Gami AS, Javaheri S, Pressman GS, Scammell TE, Surkin LA, Zee PC.   +6 more
europepmc   +1 more source

A Survey of People Living with Narcolepsy in the USA: Path to Diagnosis, Quality of Life, and Treatment Landscape from the Patient's Perspective. [PDF]

CNS Drugs
Ortiz LE, Morse AM, Krahn L, Lavender M, Horsnell M, Cronin D, Schneider B, Gudeman J.   +7 more
europepmc   +1 more source

The translational potential of sleep and circadian rhythm disturbances as a biomarker of Alzheimer's disease [PDF]

, 2018
Feldman, HH, Kent, BA, McKeown, MJ, Michalik, MM, Mirian, MS, Mistlberger, RE, Nygaard, HB, Shafiee, M, Valerio, J   +8 more
core   +1 more source

Narcolepsy: Beyond the Classic Pentad. [PDF]

CNS Drugs
Morse AM, Kim SY, Harris S, Gow M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Pharmacokinetics of Once-Nightly Sodium Oxybate FT218: Food Effect and Relative Biovailability Compared to Twice-Nightly Sodium Oxybate (629)

Neurology, 2020
David Seiden, Julien Grassot, David Monteith, Jordan Dubow   +3 more
openaire   +3 more sources

The Pharmacokinetic-Adverse Event Relationship For FT218, a Once-Nightly Sodium Oxybate Formulation (1168)

Neurology, 2020
David Seiden, Julien Grassot, David Monteith, Jordan Dubow   +3 more
openaire   +3 more sources

0589 Dose Titration of Once-Nightly Sodium Oxybate: Analysis of Interim Data From RESTORE

SLEEP, 2023
Abstract Introduction FT218 (LUMRYZ™) is an investigational once-nightly sodium oxybate (ON-SXB) for treatment of adults with narcolepsy type 1 (NT1) or type 2 (NT2). The efficacy and safety of ON-SXB at doses 6, 7.5, and 9 g in patients with NT1/NT2 were confirmed in the phase 3 REST-ON clinical ...
Asim Roy, Brian Abaluck, Thomas Stern, Clete Kushida, Jordan Dubow, Jennifer Gudeman   +5 more
openaire   +1 more source

Pharmacokinetics and Dose Proportionality of FT218, a Once-Nightly Sodium Oxybate Formulation for the Treatment of Narcolepsy (501)

Neurology, 2020
Jordan Dubow, Julien Grassot, David Monteith, David Seiden   +3 more
openaire   +3 more sources

Pharmacokinetics and Formulation Selection of FT218, a Once-Nightly Sodium Oxybate Formulation for the Treatment of Narcolepsy (495)

Neurology, 2020
Jordan Dubow, David Monteith, Julien Grassot, David Seiden   +3 more
openaire   +3 more sources